Patients & CaregiversHealthcare ProfessionalsWorldwide
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
THE MERCK MANUAL MEDICAL LIBRARY: The Merck Manual of Diagnosis and Therapy
Tips for better results
ABCDEFGHI
JKLMNOPQR
STUVWXYZ

Section

Subject

Topics

Contusions and Lacerations

Update Me

Consequences of blunt trauma to the eye range from eyelid to orbital injury.

Eyelids: Eyelid contusions (which result in black eyes) are more cosmetically than clinically significant, although more serious injuries may sometimes accompany them and should not be overlooked. Uncomplicated contusions are treated with ice packs to inhibit swelling during the first 24 to 48 h, followed by hot compresses to aid absorption of the hematoma.

Minor lid lacerations not involving the lid margin or tarsal plate may be repaired with nylon (or, in children, plain gut) 6-0 or 7-0 sutures. Lid-margin lacerations are best repaired by an ophthalmic surgeon to ensure accurate apposition and to avoid a notch in the contour. Major lid lacerations, which include those of the medial portion of the lower or upper eyelid (possibly involving the lacrimal canaliculus), through-and-through lacerations, those in which the patient has ptosis, and those that expose orbital fat or involve the tarsal plate, should also be repaired by an ophthalmic surgeon.

Globe: Trauma may cause conjunctival, anterior chamber, and vitreous hemorrhage; retinal hemorrhage, edema, or detachment; laceration of the iris; cataract; dislocated lens; glaucoma; and globe rupture (laceration). Evaluation can be difficult with massive lid edema or laceration. Even so, unless the need for immediate eye surgery is obvious (necessitating evaluation by an ophthalmologist as soon as possible), the lid is opened, taking care not to exert inward pressure, and as complete an examination as possible is conducted. At a minimum, visual acuity, pupillary responses, extraocular movements, anterior chamber depth or hemorrhage, and presence of red reflex are noted. An analgesic or, after obtaining any surgical consent, an anxiolytic may be given to facilitate examination. Gentle and careful use of eyelid retractors or an eyelid speculum makes it possible to open the lids. If a commercial instrument is not available, the eyelids can be separated with makeshift retractors fashioned by bending the ends of paper clips 180 degrees. Globe laceration should be suspected if a corneal or scleral laceration is visible, aqueous humor is leaking, the anterior chamber is very shallow (eg, making the cornea appear to have folds) or very deep (due to rupture posterior to the lens), or the pupil is irregular. If globe laceration is suspected, measures that can be taken before an ophthalmologist is available consist of applying a protective shield (see Eye Injuries: Treatment), and combating possible infection with systemic antimicrobials as discussed for intraocular foreign bodies (see Eye Injuries: Treatment). Topical antibiotics are avoided. Vomiting, which can increase intraocular pressure (IOP) and contribute to extravasation of ocular contents, is suppressed using antiemetics as needed. Because fungal contamination of open wounds is dangerous, corticosteroids are contraindicated until after wounds are closed surgically. Tetanus prophylaxis is indicated after open globe injuries. Very rarely, after laceration of the globe, the uninjured, contralateral eye becomes inflamed (sympathetic ophthalmia—see Uveitis: Sympathetic Ophthalmia) and may lose vision to the point of blindness unless treated. The mechanism is an autoimmune reaction; corticosteroid drops can prevent the process.

Anterior chamber hemorrhage (hyphema): This injury requires attention by an ophthalmologist as soon as possible. It may be followed by recurrent bleeding, glaucoma, and blood staining of the cornea, any of which may result in permanent vision loss. Symptoms are of associated injuries unless the hyphema is large enough to obstruct vision. Direct inspection typically reveals layering of blood or the presence of clot or both in the anterior chamber. Layering is seen as a meniscus-like blood level in the lower part of the anterior chamber. Microhyphema, a less severe form, may be detectable by direct inspection as haziness in the anterior chamber or by slit-lamp examination as suspended RBCs.

The patient is placed on bed rest with the head elevated 30 degrees and given an eye shield to protect the eye from further trauma (as described in Eye Injuries: Corneal Abrasions and Foreign Bodies). Patients who are at high risk of recurrent bleeding (eg, those with large hyphemas, bleeding diatheses, anticoagulant use, sickle cell disease), who have IOP that is difficult to control, or who are likely to be nonadherent to recommended treatment may be hospitalized. Oral and topical NSAIDs are contraindicated because they may contribute to recurrent bleeding. IOP can rise acutely (within hours, usually in patients with sickle cell disease or trait) or months to years later. Thus, IOP is monitored daily for several days and then regularly over subsequent weeks and months and if symptoms develop (eg, eye ache, decreased vision, nausea—similar to acute angle-closure glaucoma). If pressure rises, timolol Some Trade Names
BLOCADREN
TIMOPTIC
Click for Drug Monograph
0.5% bid, brimonidine Some Trade Names
ALPHAGAN
Click for Drug Monograph
0.2% or 0.15% bid, or both are given. Response to treatment is determined by pressure, often checked q 1 or 2 h until controlled or until a significant rate of reduction is demonstrated; thereafter, it is usually checked once or twice daily. Mydriatic drops (eg, scopolamine Some Trade Names
TRANSDERM SCOP
Click for Drug Monograph
0.25% tid or atropine Some Trade Names
ATROPEN
ATROPINE-CARE
SAL-TROPINE
Click for Drug Monograph
1% tid for 5 days) and topical corticosteroids (eg, prednisolone Some Trade Names
ORAPRED
PRELONE
Click for Drug Monograph
acetate 1% 4 to 8 times/day for 2 to 3 wk are often given. Administration of aminocaproic acid Some Trade Names
AMICAR
Click for Drug Monograph
50 to 100 mg/kg po q 4 h (not exceeding 30 g/day) for 5 days may reduce recurrent bleeding. The non-ophthalmologist should not use miotic or mydriatic drugs in these cases. Rarely, recurrent bleeding with secondary glaucoma requires surgical evacuation of the blood.

Blowout fracture: Blowout fracture occurs when blunt trauma forces the orbital contents through the most fragile portion of the orbital wall, typically the floor. Medial and roof fractures also can occur. Symptoms include diplopia, enophthalmos, inferiorly displaced globe, hypesthesia of the cheek and upper lip (from infraorbital nerve injury), and subcutaneous emphysema. Epistaxis, lid edema, and ecchymosis may occur. Diagnosis is best made by CT scan. If diplopia or cosmetically unacceptable enophthalmos persists beyond 2 wk, surgical repair is indicated. Patients should be told to avoid blowing the nose. Using a topical vasoconstrictor for 2 to 3 days may help patients with epistaxis.

Posttraumatic Iridocyclitis

(Traumatic Anterior Uveitis; Traumatic Iritis)

Posttraumatic iridocyclitis is an inflammatory reaction of the uvea and iris, typically developing within 3 days of blunt eye trauma.

Symptoms of posttraumatic iridocyclitis include tearing, throbbing ache and redness of the eye, photophobia, and blurred vision. Diagnosis is by history, symptoms, and slit-lamp examination, which typically reveals flare (due to an increase in protein content of the aqueous humor from the inflammatory exudate) and WBCs in the anterior chamber. Treatment involves a cycloplegic (usually scopolamine Some Trade Names
TRANSDERM SCOP
Click for Drug Monograph
0.25% tid, or homatropine Some Trade Names
ISOPTO
Click for Drug Monograph
5% tid). Topical corticosteroids (eg, prednisolone Some Trade Names
ORAPRED
PRELONE
Click for Drug Monograph
acetate 1% 4 to 8 times/day) are often used to shorten symptom duration.

Last full review/revision March 2007 by Kathryn Colby, MD, PhD

Content last modified March 2007

Back to Top

Previous: Burns

Next: Corneal Abrasions and Foreign Bodies

Audio
Figures
Photographs
Tables
Videos
Contact UsSite MapAccessibility StatementPrivacy PolicyTerms of UseCopyright 1995-2009 Merck & Co., Inc.